Waycross Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.4M | Buy |
|
|||||
|
2025
Q1 | $33M | Buy |
|
|||||
|
2024
Q4 | $24M | Buy |
|
|||||
|
2024
Q3 | $25.9M | Buy |
|
|||||
|
2024
Q2 | $22M | Buy |
|
|||||
|
2024
Q1 | $21.2M | Buy |
|
|||||
|
2023
Q4 | $17M | Sell |
|
|||||
|
2023
Q3 | $17.1M | Buy |
|
|||||
|
2023
Q2 | $14.8M | Buy |
|
|||||
|
2023
Q1 | $14.6M | Buy |
|
|||||
|
2022
Q4 | $12.1M | Buy |
|
|||||
|
2022
Q3 | $5.36M | Sell |
|
|||||
|
2022
Q2 | $6.16M | Buy |
|
|||||
|
2022
Q1 | $6.14M | Buy |
|
|||||
|
2021
Q4 | $4.66M | Buy |
|
|||||
|
2021
Q3 | $3.15M | Sell |
|
|||||
|
2021
Q2 | $6.38M | Buy |
|
|||||
|
2021
Q1 | $3.14M | Buy |
|
|||||
|
2020
Q4 | $1.82M | Buy |
|